Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)
Hanyong Chen(University of Minnesota Medical Center), Zigang Dong(China-US (Henan) Hormel Cancer Institute)
Cited by 17
Related Papers
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|Proceedings of the National Academy of Sciences|1994|388
Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK
|Carcinogenesis|2011|123
Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras–GTPase-Activating Protein SH3 Domain-Binding Protein 1
|Cancer Prevention Research|2010|115
Phosphorylation of Histone H3 at Serine 10 Is Indispensable for Neoplastic Cell Transformation
|Cancer Research|2005|112
(-)-Epigallocatechin Gallate Regulates CD3-mediated T Cell Receptor Signaling in Leukemia through the Inhibition of ZAP-70 Kinase
|Journal of Biological Chemistry|2008|110